Would you like to get better results?

... so use the extended search!

Login

Analytic CRM for Pharmaceutical Companies

Thanks to more than 70 participants at the two events in Munich and Vienna, there was a lively exchange of experiences and appraisals. Based on practical insights gained during the interactive business workshop one of the participants even renamed it into "Analytical regulation instead of market share depreciation." According to his conviction, limited analytic possibilities are a direct cause of market share losses. The possibility for the exchange of information and experience with other experts from the healthcare industry was used intensively.



You’ll find a glance back at the event for both dates and the photo gallery here:

 Munich | 4/24/2008
 Vienna | 4/29/2008


The industry was "x-rayed" practically under current conditions. There was almost complete agreement about three things:
  1. The generics market is in total chaos due to rapid discount contract developments
  2. In the prescription market, the therapeutic decisions are shifting from the general practitioner to the specialist or pharmacist
  3. Important marketing instruments (natural debates, trunk business) have been taken away from the OTC market
In summary, it can be said that "Analytical regulation instead of market share depreciation" means that now is the time to concern yourself intensively and integratively with the current questions and available data for the market segment. Questions such as…

  • How will we attain our company goals in the future?
  • How do we measure the return on investment on marketing measures?
  • How do we evaluate the various data sources in integrated fashion?

…must be answered as quickly as possible.

update.analytics will answer these questions for you and support your company performance in the future:
  • Industry-specific analysis solution takes off directly from your business model
  • Analyses for pharmaceutical sales and marketing answer your questions
  • Pre-defined standard analyses (visit frequency, goal achievement, etc.)
  • Easy, intuitive operation achieves high "compliance" also in the AD
  • Flexible expandability
  • Standard interfaces to external data suppliers such as IMS or InSight Health guarantee the incorporation of external data.

update.analytics does not just offer evaluations across all sales channels. Instead, it is a management instrument that directs the view to the priorities using uniform KPIs.

Here you can find more information about  update.seven analytics

or download the Product Sheet.
update.seven analytics





US Collaterals
CRM in Life Sciences

Available for download:
Product Sheet US & Industry Paper Life Sciences
update Contact
Find out how update CRM solutions can optimize your business processes:

ready, steady, »go relate«

Tel.:  +43 1 878 55 0
Fax:  +43 1 878 55 220

Contact Form